Dapagliflozin, empagliflozin and sotagliflozin for treating type 1 diabetes [ID1217]

  • Discontinued
  • GID-TA10236

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators